SPEAKERS
Dr Javad Aman, President and Chief Scientific Officer, Integrated Biotherapeutics
Dr Parastoo Azadi, Technical Director of Analytical Services and Senior Research Scientist, University of Georgia College of Veterinary Medecine
Greg Babcock, Executive Director, Research, Visterra
Siavash Bashiri, COO and Head of Biosimilars, Xbrane Biopharma Ab
David Bienvenue, Director of Protein Sciences, Aptevo Therapeutics
Dr Isaac Brownell, Investigator, Dermatology Branch, National Cancer Institute National Institutes of Health
David Bruhlmann, Associate Manager – Biotech Process Sciences Technology & Innovation, EMD Serono
Linda Bulone, Research Nurse Manager, Queens Hospital Cancer Center
Dr Alessandro Butte, Lecturer, ETH Zurich
Cindy Cao, Executive Director & Head of US Regulatory Affairs for Biopharmaceuticals, Sandoz
Dr Win-Yan Chan, Research Scientist, UCB
Qiang Chen, Professor, Biodesign Institute at Arizona State University
Mr Tony Chen, President and Chief Executive Officer, PrimeVax Immuno Oncology Inc
Hubert Chen, Chief Medical Officer, Pfenex Inc
Dr Niraj Chhaya, Lead Risk Management, Global Pharmacovigilance, Boehringer Ingelheim Pharma GmbH & Co. KG
Javier Coindreau, Vice President of Global Medical Affairs and Biosimilars, Pfizer
Matt Cooper, Business Development and Marketing Director, NIHR Clinical Research Network
Dr Gregory A. Daniels, Clinical Professor of Medicine, University California San Diego Moores Cancer Center
Brandon Dekosky, Senior Research Fellow, NIH - NIAID & University of Kansas
Richard DiCicco, Chairman, Harvest Moon Pharmaceuticals
Dr Mike Dillon, Research Associate, Genentech
Britta Eggenreich, PhD Student, Vienna University of Technology
Dr Hans Erickson, Director of Protein Chemistry, Genentech
Ted Eveleth, CEO, HocusLocus
Eleonora Ford, Director, Regulatory Affairs and R&D Policy, Amgen
Jennifer Gelman, Marketing Communication Manager, BD
Nichole Gifford, Partner, Rothwell Figg Ernst & Manbeck
Scott Glaser, Director Antibody Therapeutics, Genomics Institute of the Novartis Research Foundation
Adam Goldstein, Senior Manager Technical Operations, Genentech
Sung-Hye Grieco, Senior Engineer at Early Stage Cell Culture, PTD Department, Genetech
Thomas Gundinger, PhD student, TU Wien
Dr Andres A. Gutierrez, Chief Medical Officer, Oncolytics Biotech
Dr Tufia Haddad, Oncologist, Mayo Clinic
Karen Hauda, Senior Director of Regulatory Policy, Novo Nordisk Inc
Hooman Hefzi, Systems Biochemistry and Cell Engineering, U.C.S.D.
Kevin Heyries, Co Founder, AbCellera Biologics Inc.
Elmira Jalilian, PhD, Health Science & Technology, Harvard Medical School
Sarfaraz K Niazi, Founding Executive Chairman, Adello Biologics LLC
Martin Kane, Managing Data Scientist, Exponent
Robert Karlsson, , G.E Healthcare
Niksa Kastrapeli, Associate Director, Shire
Srinath Kasturirangan, Scientist, MedImmune Inc
Leo Kirkovsky, Director,Clinical Assay Group, Pfizer
Chrys Kokino, Head Global Biologics Commercial, Mylan
Joe Lattari, U.S. Product Manager, Process Analytics, Mettler Toledo
Prof Sy-Jye Leu, Professor, Department of Microbiology and Immunology, Taipei Medical University
Nathan Lewis, Assistant Professor, University of California San Diego
Bruce Lyday, Chief Technology Officer, PrimeVax Immuno Oncology Inc
Dr Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway
Rajiv Mahadevan, Managing Director, Precision for Medicine
Scott Marshall, Managing Director, Translational Informatics & Diagnostic Sciences, Precision For Medicine
Jim McKay, Director, Clinical Development and Medical Affairs, Sandoz
Dr Lorna McNeill, Deputy Department Chair, Department of Health Disparities Research, Division of OVP, Cancer Prevention and Population Sciences, MD Anderson Cancer Center
Dr David Meininger, Chief Business Officer, Trianni Inc
Juliane Merz, Professor, Laboratory of Plant and Process Design, Tu Dortmund University
Dr Mehran F. Moghaddam, CEO, Orox Biosciences
Dr Pankaj Mohan, Chairman, Chief Executive Officer and President, Oncobiologics Inc.
Oliver Molina, Global Manufacturing Sciences & Technology, Genentech
Valerie Mulligan, VP, Global Regulatory CMC and Growth Markets, Branded Regulatory Affairs, Teva Pharmaceuticals U.S.A.
Christopher Murriel, Senior Scientist of Cancer Biology, Oncomed Pharmaceuticals
Diane Retallack, Sr. Director, Upstream Processing and Intellectual Property, Pfenex Inc
Dr Stacie Ropka, Partner, Axinn
Teresa Safly, Area Business Manager, BD Biosciences
Blake Salisbury, VP Business Development, Innovent Biologics
Jorge Santos da Silva, Partner, McKinsey & Company
John Schiel, Research Chemist, National Institute of Standards & Technology
Susan Sharfstein, Associate Professor, S.U.N.Y. Polytechnic Institute
Dr Zachary Shriver, VP, Research, Visterra Inc.
Michael Siegel, VP of Research Programs, National Psoriasis Foundation
Dr Daniel Adriano Silva Manzano, Senior Research Fellow, University Of Washington
Andrew Simpson, Scientific Director, Orygen Biotecnologia
Dr Vaughn Smider, Assistant Professor of Molecular Biology Department of Cell and Molecular Biology, The Scripps Research Institute
Paul Song, Vice President, Business Development, Samsung Bioepis
Matthew Stauffer, Process Engineer II, Sanofi - Genzyme
Dr Don Stewart, President and Chief Executive Officer, PlantForm Corporation
Scott Tenenbaum, Associate Professor of Nanobioscience, University of Albany S.U.N.Y.
Khoi Thai, Senior Engineer Global MSAT, Drug Substance, Genentech
Nobel Vale, Research Scientist II, Bristol Myers Squibb
David Wood, Associate Professor of Chemical and Bio molecular Engineer, The Ohio State University
Bo Yu, Co Founder and Chief Scientific Officer, Larix Bioscience Llc
Organiser
